terazosin
UkraineDrugs containing this active substance
-
The drug is used for the symptomatic treatment of urinary retention in benign prostatic hyperplasia, as well as for the treatment of arterial hypertension (either alone or in combination with other agents).
Form: tablets
Active substance Dosage terazosin 1 mg ATC: G04CA03
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used for the symptomatic treatment of urinary retention in benign prostatic hyperplasia, as well as for the treatment of arterial hypertension (it can be used either alone or in combination with other blood pressure medications).
Form: tablets
Active substance Dosage terazosin 2 mg ATC: G04CA03
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used for the symptomatic treatment of urinary retention in benign prostatic hyperplasia, as well as for the treatment of arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage terazosin 5 mg ATC: G04CA03
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used for the symptomatic treatment of urinary retention in benign prostatic hyperplasia, as well as for the therapy of arterial hypertension (high blood pressure).
Form: tablets
Active substance Dosage terazosin 10 mg ATC: G04CA03
Manufacturer: PJSC Pharmaceutical Plant EGIS